Literature DB >> 6506111

Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.

L E Brattstrom, J E Hardebo, B L Hultberg.   

Abstract

Highly elevated concentrations of homocysteine measured as homocysteine or cysteine-homocysteine mixed disulfide (MDS) are found in plasma and urine in subjects with inherited abnormalities of the methionine metabolism. These subjects have a high incidence of arteriosclerotic vascular complications during childhood. Homocysteine causes endothelial cell injury and cell detachment that initiates the development of arteriosclerosis. The present study demonstrates a significantly elevated mean plasma MDS concentration in 19 patients with arteriosclerotic cerebrovascular disease compared to 17 controls. Our findings suggest that moderate homocysteinemia might be a risk factor for arteriosclerotic cerebrovascular disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6506111     DOI: 10.1161/01.str.15.6.1012

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

1.  Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency.

Authors:  E Ronge; B Kjellman
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

2.  Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone.

Authors:  S C Tyagi; L M Smiley; V S Mujumdar; B Clonts; J L Parker
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

3.  Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry.

Authors:  S P Stabler; P D Marcell; E R Podell; R H Allen; D G Savage; J Lindenbaum
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Association of MTHFR C677T polymorphism and risk of cerebrovascular disease in Chinese population: an updated meta-analysis.

Authors:  Ming-Jie Zhang; Jing-Cheng Li; Yan-Wei Yin; Bing-Hu Li; Yun Liu; Shao-Qiong Liao; Chang-Yue Gao; Li-Li Zhang
Journal:  J Neurol       Date:  2014-03-07       Impact factor: 4.849

5.  Influence of renal function on the association between homocysteine level and risk of ischemic stroke.

Authors:  Yao Cheng; Fan-Zhen Kong; Xiao-Feng Dong; Qin-Rong Xu; Qian Gui; Wei Wang; Hong-Xuan Feng; Wei-Feng Luo; Zong-En Gao; Guan-Hui Wu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

6.  Plasma homocysteine status in patients with ankylosing spondylitis.

Authors:  James Cheng-Chung Wei; Ming-Shiou Jan; Chen-Tung Yu; Yi-Chia Huang; Chi-Chiang Yang; Hsi-Kai Tsou; Hong-Shan Lee; Chang-Tei Chou; Gregory Tsay; Ming-Chih Chou
Journal:  Clin Rheumatol       Date:  2006-09-21       Impact factor: 2.980

7.  The relationship between plasma homocysteine level and different treatment modalities in patients with ankylosing spondylitis.

Authors:  Erhan Capkin; Murat Karkucak; Ayşe Akyüz; Ahmet Alver; Aysegul Kucukali Turkyilmaz; Elif Zengin
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

Review 8.  Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.

Authors:  Elisabetta Trabetti
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

9.  Hyperhomocysteinaemia: a risk factor for extracranial carotid artery atherosclerosis.

Authors:  R Clarke; D Fitzgerald; C O'Brien; C O'Farrell; G Roche; R A Parker; I Graham
Journal:  Ir J Med Sci       Date:  1992-03       Impact factor: 1.568

10.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

Authors:  G Starkebaum; J M Harlan
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.